Public Joint-Stock Company "Human Stem Cells Institute"
ISKJ.ME
Price:
$77.1
Market Cap:
$6.55B
Public Joint-Stock Company 'Human Stem Cells Institute' operates as a biotech company primarily in Russia. The company engages in the drug discovery, research and development, and marketing of proprietary products and services in the field of regenerative medicine; bio-insurance; medical genetics, including reproductive genetics; gene therapy; and biopharmaceutics. It owns and operates Gemabank, a family cord blood stem cell bank in Russia and the CIS; and Reprobank, a reproductive cell and tissue bank for personal storage of reproductive cells and tissues, as well as a sperm/oocyte donation. The company also offers Neovasculgen, a gene-therapy drug for treatment of peripheral arterial disea...[Read more]
Industry
Biotechnology
IPO Date
2010-03-03
Stock Exchange
MCX
Ticker
ISKJ.ME
PE Ratio
[296.54]
ROE
[51.17%]
Current Ratio
[2.29]
Dividend Yield
[1.56%]
Enterprise Value
[6.79B]
Dividend History
ISKJ.ME Dividend History Overview
Dividends are a key part of long-term returns for investors, and Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) has a track record worth reviewing. Looking at dividend history for ISKJ.ME gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2024-06-17
Dividend Yield
1.56%
Annual Dividend
$1.20
P/E Ratio
296.54
Payout Ratio
0.65
Dividend per Share
$1.20
EPS
0.26
| Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
|---|---|---|---|---|
| 2024-06-17 | $1.2 | $1.2 | ||
| 2023-07-18 | $1 | $1 | ||
| 2023-07-11 | $1 | $1 | ||
| 2016-06-29 | $0.3 | $0.3 | 2016-08-01 | 2016-05-17 |
| 2014-06-27 | $0.15 | $0.15 | 2014-08-01 | 2014-05-19 |
| 2010-04-26 | $0.1 | $0.1 | 2010-07-01 |
Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) Dividend History Chart
The table below shows Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) Dividend Growth
Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Other Popular Dividend Stocks
Check out the dividend history of other popular stocks:
| Stock name | Dividend yield |
|---|
Track & Identify Dividend Stocks
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) without the pain and hassle of copy pasting data.
Frequently asked questions❓
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is ISKJ.ME’s dividend yield?
What is the difference between regular and special dividends?
Has ISKJ.ME increased its dividends over time?
Why might dividend history data be delayed?
How often does ISKJ.ME pay dividends?
What factors impact ISKJ.ME's dividend payments?
Can dividends change over time?
What is ISKJ.ME’s next dividend date?